BridgeMD
New treatment option for Pancreatic Neoplasms
Official title PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
ClinicalTrials.gov ID: NCT05172310
What this study is testing
What is 68Ga-FAPI-46?
68Ga-FAPI-46 is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for pancreatic neoplasms.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Cancers of the pancreas, bile ducts, stomach and ovaries are dismal diseases with most patients being diagnosed in advanced stages leading to a bad prognosis. These cancers can be difficult to diagnose and sometimes impossible to differentiate from underlying benign conditions.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Consecutive patients scheduled for surgical removal of either a pancreatic, biliary or gastric lesion. \- Consecutive patients scheduled for primary...
- Signed informed consent. Common
You likely can't join if
- for all study populations:
- Age ≤18 year
- Pregnancy and lactation
- Significantly reduced renal function
- Allergy to iodinated contrast media
- people that for some reason are unable to exercise their own rights, such as cognitive function impairment. Additional Exclusion Criteria for study...
See the full eligibility criteria
- Consecutive patients scheduled for surgical removal of either a pancreatic, biliary or gastric lesion. \- Consecutive patients scheduled for primary surgical removal of early stage epithelial ovarian cancer (EOC)...
- Signed informed consent. Common
- for all study populations:
- Age ≤18 year
- Pregnancy and lactation
- Significantly reduced renal function
- Allergy to iodinated contrast media
- people that for some reason are unable to exercise their own rights, such as cognitive function impairment. Additional Exclusion Criteria for study populations with either pancreatic-, gastric or bile duct cancer:
- Known metastatic disease
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.